Nanosonics is a ASX-listed company in the healthcare industry which manufactures and distributes ultrasound probe disinfectors and other related technologies. It has offices in Australia, the U.S. and Canada, the United Kingdom and Europe, employing more than 300 people. The company’s Trophon is the product used to reduce the spread of Healthcare Acquired Infections (HAIs). Its Trophon2 product includes AcuTrace technology, which enables digital record keeping and provides workflows for ultrasound probe high level disinfection.

History

The company was founded in 2001 and headquartered in

Sydney Sydney ( ) is the capital city of the state of New South Wales, and the most populous city in both Australia and Oceania. Located on Australia's east coast, the metropolis surrounds Sydney Harbour and extends about towards the Blue Mountain ...

, Australia. It listed on the

Australian Securities Exchange Australian Securities Exchange Ltd or ASX, is an Australian public company that operates Australia's primary securities exchange, the Australian Securities Exchange (sometimes referred to outside of Australia as, or confused within Australia as ...

(ASX) in 2007 with the ticker NAN. In 2009, it launched Trophon, a unique, automated technology for the high-level disinfection of intracavity and surface ultrasound probes. In 2010 Nanosonics warned that it had become aware of a substandard component being used in the production of its Tryphon EPR ultrasound disinfectant device and had moved to rectify the problem. In March 2015, Nanosonics was included in the ASX300 Index (Australia’s top 300 companies by market capitalisation). In 2018 investors were cautioned about Nanosonics relying too much on only one customer, which had its own financial problems, as an outlet for its products. The

COVID-19 pandemic The COVID-19 pandemic, also known as the coronavirus pandemic, is an ongoing global pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The novel virus was first identif ...

saw Nanosonics share price drop 25 per cent in the first quarter of 2021 due to a ban on elective surgeries and drop off in demand for ultrasound cleaning devices.

References

External links

* {{DEFAULTSORT:Nanosonics Companies based in New South Wales Companies based in Sydney Companies listed on the Australian Securities Exchange Australian brands Australian companies established in 2001